Enable Accessibility Enable Accessibility

Quarterly Results FY2020 (April 2020-March 2021)

Document Q1 Q2 Q3 Q4
Press Release PDF.png PDF.png PDF.png PDF.png
Quarterly Financial Report PDF.png PDF.png PDF.png PDF.png
Presentation (for Investors) PDF.png PDF.png PDF.png PDF.png
Databook PDF.png PDF.png PDF.png PDF.png
Highlight Video microphone.png microphone.png microphone.png microphone.png
Webcast/ Audio #1 microphone.png microphone.png microphone.png microphone.png
#2 microphone.png microphone.png microphone.png
Underlying Core Reconciliation PDF.png PDF.png PDF.png PDF.png
Earnings FAQs PDF.png PDF.png PDF.png PDF.png
Clinical Trial Summary PDF.png
Financial Statements (Tokyo Stock Exchange filing) PDF.png PDF.png PDF.png PDF.png
Annual Securities Report/
Quarterly Securities Report *
PDF.png PDF.png PDF.png PDF.png
Form 20-F (SEC filing) PDF.png

 

For Media Q1 Q2 Q3 Q4
Presentation PDF.png PDF.png
Webcast/ Audio microphone.png microphone.png


#1: Conference call (Call 1: Presentation and Q&A Session)
#2: U.S. timezone call (Call 2: Q&A Session only)

* The English version of the Annual Securities Report/Quarterly Securities Report is provided as a reference material to assist foreign inventors in understanding the Securities Report, which was filed with Japanese FSA (Financial Services Agency). We do not provide assurance about the accuracy, validity, or coverage of the English translation of this document, and if the description and explanation of this document differs from those of the Japanese Annual Securities Report/Quarterly Securities Report which was filed, the Securities Report in Japanese shall prevail.